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Abstract 
 
Objective: To evaluate rapid eye movement (REM) muscular activity in narcolepsy by applying 
five algorithms to electromyogram (EMG) recordings, and to investigate its value for narcolepsy 
diagnosis.  
Patients/methods: A modified version of phasic EMG metric (mPEM), muscle activity index 
(MAI), REM atonia index (RAI), supra-threshold REM EMG activity metric (STREAM), and 
Frandsen method (FR) were calculated from polysomnography recordings of 20 healthy controls, 18 
clinic controls (subjects suspected with narcolepsy but finally diagnosed without any sleep 
abnormality), 16 narcolepsy type 1 without REM sleep behavior disorder (RBD), 9 narcolepsy type 1 
with RBD, and 18 narcolepsy type 2. Diagnostic value of metrics in differentiating between groups 
was quantified by area under the receiver operating characteristic curve (AUC). Correlations among 
the metrics and cerebrospinal fluid hypocretin-1 (CSF-hcrt-1) values were calculated using linear 
models. 
Results: All metrics excluding STREAM found significantly higher muscular activity in 
narcolepsy 1 cases versus controls (p<0.05). Moreover, RAI showed high sensitivity in the detection 
of RBD. The mPEM achieved the highest AUC in differentiating healthy controls from narcoleptic 
subjects. The RAI best differentiated between narcolepsy 1 and 2. Lower CSF-hcrt-1 values 
correlated with high muscular activity quantified by mPEM, sMAI, lMAI, PEM and FR (p<0.05). 
Conclusions: This automatic analysis showed higher number of muscle activations in narcolepsy 
1 compared to controls. This finding might play a supportive role in diagnosing narcolepsy and in 
discriminating narcolepsy subtypes. Moreover, the negative correlation between CSF-hcrt-1 level 
and REM muscular activity supported a role for hypocretin in the control of motor tone during REM 
sleep. 
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Introduction 
 
Narcolepsy is a neurological sleep disorder characterized by excessive daytime sleepiness (EDS), 
sudden onsets of rapid eye movement (REM) sleep periods during wakefulness, and a general 
disturbed pattern of nocturnal sleep. The disorder is currently recognized as either narcolepsy type 1 
(NT1) or narcolepsy type 2 (NT2) [1]. NT1 patients are associated with cataplexy, which for the 
majority of patients is caused by a loss of hypothalamic hypocretinergic cells leading to lower 
cerebrospinal fluid (CSF) hypocretin-1 (hcrt-1) levels than in the general population. The loss of 
cells is likely due to an autoimmune-mediated destruction of hypocretinergic brain cells [2–5]. The 
mechanism for NT2 is unknown but is most likely heterogeneous [6]. 
The current diagnosis of NT1 is based on medical history of patients exhibiting EDS for at least 3 
months and the presence of one or both of the following: 1) cataplexy combined with a positive 
multiple sleep latency test (MSLT) with a mean sleep latency <8 minutes and the presence of at least 
two sleep onset REM periods (REM sleep latency ≤15 minutes) during the polysomnogram (PSG) 
and 4-5 daytime nap opportunities; and 2) CSF-hcrt-1 levels ≤110 pg/mL, or less than one third of 
the mean values obtained in normal subjects with the same standardized assay. The NT2 present 
normal CSF-hcrt-1 levels [1]. 
Recent studies have also shown that a positive MSLT in NT2 is often not a repeatable clinical 
feature, raising questions regarding the diagnostic entity [7]. Indeed, false positive MSLTs are 
associated with shift work and sleep deprivation [8]. Due to variation in interpretation and day-to-
day variations in PSG/MSLT [9,10], other diagnostic procedures have been proposed for diagnosing 
narcolepsy, including reports of sleep stages [11-16], and autonomic disturbance findings during the 
PSG [17].  
A promising supportive diagnostic procedure for narcolepsy might be the analysis of abnormal 
muscular activity during REM sleep. In fact, in NT1, REM sleep without atonia (RSWA) and 
clinical signs indicative of REM sleep behavior disorder (RBD) have been frequently reported [18-
20]. Current hypotheses claim that an association between RBD and NT1 might be caused by a 
common dysregulation of the dopamine system [21]. Therefore, abnormal REM muscular activity 
could also be considered a diagnostic feature. Unfortunately, there is a lack of standardization in the 
identification of abnormal motor activity during sleep, which has to be overcome in order to make 
this feature useful for diagnostic purposes. Recently, there has been an increased focus on 
automatizing the quantification of muscle activity using either the original definitions of phasic and 
tonic activations [22] or novel computer detection approaches derived thereof [23,24].  
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The current study attempted to objectively quantify EMG activity in narcolepsy patients, focusing 
on five different automatic detection approaches using quantitative measures derived from the chin 
EMG: 1) a modified version of the phasic electromyographic metric (mPEM) [25]; 2) the muscle 
activity index (MAI) [26]; 3) the REM atonia index (RAI) [27]; 4) the suprathreshold REM EMG 
activity metric (STREAM) [28]; and 5) the automated method proposed by Frandsen et al. (FR) [29]. 
The current study aimed to: 1) investigate the previously mentioned computer detection approaches 
with respect to detection of EMG changes in narcoleptic sleep; 2) investigate whether the automated 
analysis of EMG might be used as a supportive diagnostic tool for narcolepsy using a single 
overnight PSG; and 3) investigate the relationship between CSF-hcrt-1 values and abnormal 
muscular activity in REM sleep. 
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Methods 
 
Subjects and recordings 
A total of 81 subjects were included in this study, which consisted of one healthy control group 
and four patient groups. The healthy control (C) group comprised 20 healthy subjects with no 
previously diagnosed sleep disorders and no suspicion of narcolepsy. Patients were admitted to the 
sleep clinic under suspicion of narcolepsy and underwent standard PSG-MSLT procedures [30], 
including CSF-hcrt-1 measurements [31]. After clinical tests, patients were divided into four groups: 
1) 18 patients with normal CSF-hcrt-1 levels and no diagnosis of narcolepsy or other primary sleep 
disorders (sleep clinic controls, SCC); 2) 16 patients diagnosed with NT1 (NT1-RBD); 3) 9 patients 
diagnosed with NT1 and RBD (NT1+RBD); and 4) 18 subjects diagnosed with NT2. The RBD 
diagnosis was based on anamnesis, questionnaires and video-PSGs, which were scored by 
technicians according to American Academy of Sleep Medicine (AASM) rules. Subject 
demographics are shown in Table 1, including gender, age, CSF-hcrt-1 level, BMI, sleep stage 
distributions, and known medication. All patients were advised to discontinue medications known to 
affect normal sleep behavior, such as centrally acting stimulants and medications for cataplexy, at 
least 2 weeks prior to the PSG recording.  
All PSGs were recorded at the Danish Center for Sleep Medicine in accordance with AASM 
standards [30], with a sampling frequency of 256 Hz. Only the chin EMG channel was used in the 
current study. Ten PSGs (two C, three SCC, two NT1-RBD, and three NT2 patients) were dismissed 
from further analysis due to unacceptable noise. The EMG signals were recorded with different 
amplifier systems, in which the lowest cut-off frequency for the built-in anti-aliasing filter was 
70 Hz. For the sake of uniformity, all EMG signals were low-pass filtered with a fourth-order 
Butterworth zero-phase low-pass filter with a cut-off at 70 Hz. Moreover, recordings were digitally 
filtered with a 10 Hz Butterworth high-pass filter and notch filtered at 50 Hz using a zero-phase 
filtering procedure. All algorithms were implemented in MATLAB (R2016a, The MathWorks, 
Natick, MA, USA).  
The study was accepted by the Danish Health Authority and the Data Protection Agency. All data 
were anonymized. The work was carried out in accordance with the Declaration of Helsinki. 
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Table 1. Demographic data for the five studied groups.  
Parameter C SCC NT1-RBD NT1+RBD NT2 p 
Total count 20 18 16 9 18 - 
Fraction of men 0.45 0.39 0.63 0.67 0.44 0.509 
Age, years, µ±σ 34.1±7.8 37.7±11.4 34.7±18.7 26.7±21.1 29.2±11.7 0.241 
BMI, kg/m2, µ±σ 25.6±6.7 23.9±4.2 27.5±3.8 22.8±4.6 23.1±3.5 0.036 
CSF hypocretin 1 
level 
- 401.9±62.2 33.8±29.8 27..3±21.5 332.9±98.7 - 
Sleep efficiency, %, 
µ±σ 
91.1±6.8 86.4±15.1 85.4±10.9 87.7±9.3 93.4±3.1 0.133 
Time in bed, 
minutes, µ±σ 
471.9±40.9 478.9±33.8 472.5±54.4 455.1±68.0 511.5±142.2 0.863 
REML, minutes, µ±σ 100.4±52.5 97.1±33.2 88.31±98.4 34.1±44.0 109.3±114.6 0.011 
W, %, µ±σ 8.9±6.8 13.6±15.1 14.5±11.0 12.3±9.3 6.6±3.1 0.149 
REM, %, µ±σ 20.4±4.9 18.2±7.4 17.4±7.2 22.7±5.2 20.2±6.9 0.163 
N1, %, µ±σ 4.8±2.2 5.7±3.3 11.8±7.8 10.4±7.6 5.3±3.1 0.008 
N2, %, µ±σ 45.0±8.3 43.1±10.7 42.4±12.1 35.7±9.7 48.1±11.6 0.135 
N3, %, µ±σ 20.8±8.1 19.3±7.8 13.9±6.9 18.8±13.8 19.8±8.5 0.071 
Fraction of subjects 
taking stimulant 
medication 
0 0.06 0.25 0.33 0.17 0.059 
Fraction of subjects 
taking anti-cataplexy 
medication 
0 0 0 0.33 0.22 0.003 
Fraction of subjects 
taking both stimulant 
and anti-cataplexy 
medication 
0 0 0 0.33 0 <0.001 
C, healthy controls; SCC, sleep clinic controls; NT1±RBD, type 1 narcolepsy with/without RBD; 
NT2, type 2 narcolepsy; BMI, body mass index; CSF, cerebrospinal fluid; REML, REM sleep 
latency; REM, rapid eye movement;  
 p-values were obtained with Kruskal-Wallis tests and Chi-squared tests for fractions.  
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Modified phasic electromyographic metric (mPEM) 
An automatic way of calculating the PEM was developed in accordance with the original visual 
scoring method [25]. However, because of the absence of a well-defined pre-sleep period, the 
definition of the baseline level was changed as described in the following. A phasic activation must 
fulfill three criteria: 1) activation above four times the baseline; 2) activation between 0.1-2.5 
seconds in duration; and 3) clear return to baseline after each activation. In order to meet these 
criteria, 1) the baseline was defined in 30-second epochs as the median of the absolute value of the 
EMG in these epochs. Then, 2) 2.5-second mini-epochs were considered and for each of them 
activations were found when the EMG was above four times the baseline previously defined, and the 
activations lasting <0.1 second were removed. Finally, 3) activations within the last 10 samples of 
the 2.5-second mini-epochs were removed from further analysis, as these would have no clear return 
to baseline. The fraction of mini-epochs in REM sleep meeting the requirements was reported as the 
PEM. It is worth noticing that the method proposed in [25] was applied to EMG signals filtered 
between 10-100 Hz.  
 
Muscle activity index (MAI) 
To detect abnormal muscular activity, the amplitude EMG signal was calculated from the original 
EMG signal as the difference between an upper and lower envelope calculated by linear interpolation 
between the upper and lower waveform peaks, respectively. The amplitude signal was then smoothed 
over 0.025 seconds using a moving average filter. A baseline was extracted by smoothing the 
amplitude signal over 200 seconds and the threshold was defined as four times the baseline. In the 
original paper, the threshold was defined as twice the baseline level [26]; however, in the current 
study it was found that this threshold level was too susceptible to noise and it was decided to set the 
threshold at four times the baseline instead (an example supporting this choice is shown in Appendix 
Fig. A1). This is in accordance with the original specifications used by Lapierre and Montplaisir 
[22], and has been extensively used in other studies [18,25,29,32]. The EMG activity was detected 
when the amplitude signal exceeded the threshold curve, and clusters of activity <1-second distance 
were defined as one unique event. The long-lasting and short-lasting muscle activity indexes (lMAI 
and sMAI) were defined as the number of activity events/hour of REM sleep above and below 0.5 
seconds in length, respectively. It should be noticed that the method proposed in [26] was applied to 
EMG filtered in the range 10-100 Hz. 
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REM atonia index (RAI) 
The EMG signal was rectified and the amplitude in each 1-second mini-epoch was calculated as 
the average amplitude in that mini-epoch minus the minimum amplitude in a surrounding moving 
window of 30 seconds, in order to reduce the noise influence. The obtained amplitudes (amp) of each 
1-second mini-epoch were then divided into 20 stage-specific categories according to their values 
(ie, amp ≤1 µV, 1 µV≤ amp ≤2 µV, …, 18 µV≤ amp ≤19 µV and amp ≥20 µV). By considering only 
the 1-second mini-epochs in REM stage, the RAI was calculated as the percentage of amp ≤1 µV 
divided by the sum of the number of mini-epochs with amp ≤1 µV and those with amplitudes >2 µV 
(ie, excluding those with 1 µV< amp ≤2 µV) [27,33]. It has to be noted that the method proposed in 
[27,33] was applied to EMG signals filtered between 10-100 Hz.  
 
Supra-threshold REM activity metric (STREAM) 
Each recording was divided into 3-second mini-epochs and the sample variance for each mini-
epoch calculated. The STREAM was computed as the percentage of REM mini-epochs with sample 
variance larger than a threshold defined as four times the fifth percentile of the observed sample 
variance during all NREM mini-epochs [28]. 
 
Frandsen method (FR) 
Frandsen et al. proposed an optimized method for quantifying submental motor activity during 
REM sleep. After the filtering, an amplitude curve (AC) was generated by calculating the difference 
between the highest and lowest EMG values within an ~200 ms moving window. Then, the AC was 
divided in 30-second segments and the median amplitude (MA) calculated for each of them. For 
each of these segments, the baseline was identified as the lowest MA in the period 30 minutes before 
and 30 minutes after the current segment. Muscular activity was then identified when the AC was 
above four times the baseline and with a minimum duration of 0.3 seconds. Moreover, clusters of 
muscular activity at a distance <0.5 seconds were considered as a unique muscular activation. 
Finally, the REM sleep mini-epoch index (FR) was calculated as the percentage of 3-second mini 
epochs in REM sleep with muscle activity events in >50% of the time. The implementation of the 
different algorithms was validated on a visual basis. 
 
Statistical analysis 
Between-group comparisons were performed using a Kruskal-Wallis test. Post-hoc comparisons 
were performed with a Mann-Whitney U-test with Tukey-Kramer correction at a significance level 
of p=0.05, and the effect size for each comparison was calculated according to [34]. Diagnostic value 
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and performance were quantified by sensitivity, specificity and the area under the receiver operating 
characteristic (ROC) curve (AUC). In particular, performance was measured using AUC values and 
the largest sensitivity at which there was a minimum of 97% specificity. Linear regression models 
were used to assess relationships between metrics and CSF-hcrt-1 levels, with correlation being 
evaluated using Pearson’s correlation coefficient and Student’s t-test for significance. For all the 
metrics (RAI excluded) and CSF-hcrt-1 values, log-transformation was used, while for the RAI 
metric the log(100-RAI) was applied to obtain positive correlations. All model residuals were 
checked for normality. 
 
Results 
Fig. 1 a)-f) show mPEM, STREAM, sMAI, lMAI, RAI and FR metrics, respectively, visualized 
by boxplots with group means designated by crosses, medians designated by horizontal lines, and the 
25th and 75th percentiles designated by the bottom and top end of the blue box. Average and standard 
error of the mean values of the different metrics are shown in Table 2 together with the p-value of 
the between-groups comparison. Table 3 shows the p-values of the post-hoc comparison tests and the 
effect size of each comparison.  
A comparison of the diagnostic value and performance of these different metrics is shown Table 
4. The choice of the different combinations shown for AUC analysis is explained in the discussion 
section. Finally, the results of correlation analysis are shown in Fig. 2.  
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Table 2. Electromyogram analyses results across subject groups.  
 C SCC NT1-RBD NT1+RBD NT2 p 
sMAI, hours 
REM 
87.1 (3.0) 91.5 (3.4) 161.8 (5.0) 127.4 (5.3) 137.8 (5.4) 0.0056 
lMAI, hours 
REM 
46.8 (2.0) 35.0 (0.9) 104.9 (4.3) 72.2 (5.2) 54.8 (2.3) 0.0015 
mPEM, % 10.8 (0.3) 13.6 (0.4) 25.7 (0.6) 19.2 (1.0) 15.8 (0.7) 0.0004 
RAI, % 96.9 (0.2) 96.1 (0.3) 93.0 (0.3) 89.8 (1.4) 96.4 (0.2) 0.0008 
STREAM, % 7.9 (0.2) 14.1 (0.9) 15.2 (0.9) 16.6 (1.7) 19.4 (1.2) 0.0529 
FR, % 11.2 (0.5) 13.3 (0.8) 20.8 (0.8) 19.5 (1.2) 12.9 (0.6) 0.0050 
 
Results are displayed as mean (standard error of the mean), as well as the p-values for the Kruskal-
Wallis test for each feature.  
C, healthy controls; SCC, sleep clinic controls; NT1±RBD, type 1 narcolepsy with/without RBD; 
NT2, narcolepsy type 2; sMAI, short muscle activity index; lMAI, long muscle activity index; 
mPEM, modified phasic electromyographic metric; RAI, REM atonia index; STREAM, supra-
threshold REM EMG activity metric; FR, Frandsen method; REM, rapid eye movement 
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Table 3. P-values obtained for the post-hoc comparisons by using a Mann-Whitney U-test with 
Tukey-Kramer correction highlighted by significance (p<0.05) and relative effect size in parentheses.  
 sMAI lMAI mPEM RAI FR 
C vs SCC 
0.9948 
(–0.03) 
0.9757 
(0.07) 
0.8822 
(–0.17) 
0.9944 
(0.06) 
0.9940 
(–0.11) 
C vs NT1-RBD 
0.0153 
(–0.50) 
0.0121 
(–0.49) 
0.0002 
(–0.66) 
0.0167 
(0.48) 
0.0154 
(–0.46) 
C vs NT1+RBD 
0.1668 
(–0.46) 
0.2735 
(–0.42) 
0.1100 
(–0.50) 
0.0079 
(0.61) 
0.0584 
(–0.45) 
C vs NT2 
0.1392 
(–0.38) 
0.9101 
(–0.11) 
0.4083 
(–0.25) 
0.9481 
(0.14) 
0.7535 
(–0.21) 
SCC vs NT1-RBD 
0.0660 
(–0.45) 
0.0026 
(–0.60) 
0.0122 
(–0.54) 
0.0721 
(0.44) 
0.0687 
(–0.43) 
SCC vs NT1+RBD 
0.3527 
(–0.37) 
0.1111 
(–0.53) 
0.5198 
(–0.31) 
0.0322 
(0.53) 
0.1634 
(–0.47) 
SCC vs NT2 
0.3505 
(–0.24) 
0.6292 
(–0.22) 
0.9394 
(–0.14) 
0.9978 
(0.06) 
0.9441 
(–0.15) 
NT1-RBD vs 
NT1+RBD 
0.9901 
(0.13) 
0.9389 
(0.23) 
0.7320 
(0.32) 
0.9763 
(0.06) 
1 
(0.06) 
NT1-RBD vs NT2 
0.9257 
(0.11) 
0.1600 
(0.39) 
0.1055 
(0.40) 
0.1522 
(–0.38) 
0.3336 
(0.36) 
NT1+RBD vs NT2 
0.9992 
(0.00) 
0.7484 
(0.16) 
0.8974 
(0.15) 
0.0690 
(–0.55) 
0.5016 
(0.33) 
 
C, healthy controls; SCC, sleep clinic controls; NT1±RBD, type 1 narcolepsy with/without RBD; 
NT2, narcolepsy type 2; sMAI, short muscle activity index; lMAI, long muscle activity index; 
mPEM, modified phasic electromyographic metric; RAI, REM atonia index; FR, Frandsen method 
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Table 4. Comparison of the diagnostic value and performance of the five different metrics, given as 
area under the curve (AUC) (sensitivity/specificity). Sensitivity was calculated at the point of a 
minimum of 97% specificity.  
 sMAI lMAI mPEM RAI STREAM FR 
C vs 
NT1+NT2 
0.784 
(0.158/1) 
0.708 
(0.132/1) 
0.794 
(0.395/1) 
0.741 
(0.222/0.974) 
0.737 
(0.290/1) 
0.731 
(0.132/1) 
SCC vs 
NT1+NT2 
0.725 
(0.079/1) 
0.779 
(0.368/1) 
0.712 
(0.132/1) 
0.700 
(0.133/0.974) 
0.597 
(0.026/1) 
0.714 (0/1) 
NT1 vs 
NT2 
0.542 
(0.044/1) 
0.693 
(0.261/1) 
0.696 (0/1) 0.788 
(0.267/1) 
0.533 (0/1) 0.725 
(0.044/1) 
NT1-RBD 
vs 
NT1+RBD 
0.587 
(0.214/1) 
0.651 
(0.071/1) 
0.706 
(0.071/1) 
0.540 
(0.286/1) 
0.587 (0/1) 0.540 
(0.143/1) 
C, healthy controls; SCC, sleep clinic controls; NT1±RBD, type 1 narcolepsy with/without RBD; 
NT2, narcolepsy type 2; sMAI, short muscle activity index; lMAI, long muscle activity index; 
mPEM, modified phasic electromyographic metric; RAI, RAI atonia index; STREAM, supra-
threshold REM EMG activity metric; FR, Frandsen method 
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Fig. 1. a) Modified phasic electromyogram metric (mPEM); b) supra-threshold rapid eye movement 
electromyogram activity metric (STREAM); c) short muscle activity index (sMAI); d) long muscle 
activity index (lM I); e) rapid eye movement atonia index (RAI); and e) Frandsen metric (FR) 
across subject groups shown as box plots with crosses denoting group means. 
 C, healthy controls; SCC, sleep clinic controls; NT1±RBD, type 1 narcolepsy with/without RBD; 
NT2, narcolepsy type 2 
*p<0.05 
**p<0.01 
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***p<0.001 
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Fig. 2. Correlation plots and analysis between metrics. All the metrics (RAI excluded) and CSF-1-
hcrt levels are log-transformed, and log(100-RAI) was used. Colors in the left boxes represent the 
correlation values, and significant p-values for the correlation are highlighted. In the diagonal, the 
distributions of the metrics are shown.  
sMAI, short muscle activity index; lMAI, long muscle activity index; mPEM, modified phasic 
electromyographic metric; RAI, REM atonia index; REM, rapid eye movement; STREAM, supra-
threshold REM electromyography activity metric; FR, Frandsen method; hcrt, hypocretin 
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Discussion 
 
The results in Fig. 1a)-f) and Tables 2 and 3 show that all the metrics (STREAM excluded) found 
elevated REM EMG activity in NT1-RBD compared to C, which is in agreement with the muscular 
abnormalities in NT1 observed in previous studies [18-20]. Increase in REM EMG activity was also 
observed when SCC were compared to NT1-RBD, but statistical difference was obtained only by 
lMAI and mPEM, while sMAI, RAI and FR were close to significance level. All the metrics 
presented a medium effect size when C/SCC were compared to NT1-RBD, with mPEM showing the 
highest value. These results further confirm that NT1 subjects are characterized by abnormal REM 
muscular activity. Compared to the other metrics, RAI was more sensitive to detect RBD as a 
comorbidity of NT1, since it was the only one showing statistical difference between NT1+RBD and 
C/SCC with a medium effect size. It is interesting to observe that RAI presented significant or close-
to-significance p-values when NT1±RBD patients were compared to other groups. This means that 
this metric has the potential to quantify the abnormal muscular movements during REM that have 
previously been observed [18–20]. However, it must be noticed that the authors of RAI proposed that 
healthy subjects are characterized by values >90% [27]. If this threshold was applied in this study, 
the majority of subjects would have been considered healthy. Low sample size in the current study 
and inter-clinic variability due to differences in recording equipment may have influenced these 
results. It may be that introducing subject-specific amplitude criteria based on NREM value features, 
such as in the STREAM calculations, would improve applicability to other datasets. 
The AUC analysis performed in Table 4 was performed in order to understand whether 
automatically detected REM EMG activity could be used as a tool to diagnose and differentiate 
narcolepsy with high specificity, according to the scheme shown in Fig. 3. When a subject is referred 
to the clinic, it is first desirable to understand whether he/she has narcolepsy, then which type it is, 
and in case of NT1, whether RBD is present or not. Fig. 3 illustrates the decision hierarchy on the 
role of RSWA in the diagnosis of narcolepsy in the top tier, and RBD as a comorbidity of NT1 in the 
lowest tier.  
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Fig. 3. Schematic representation of the diagnostic decisions made with the proposed automatic 
analysis of REM-EMG activity. The presence of narcolepsy is first analyzed, then which type of 
narcolepsy, and finally in case of NT1 the presence of comorbid RBD is noted. 
 
 
The results in Table 4 show that the applied metrics showed promising diagnostic performances in 
discriminating healthy subjects (C/SCC) from the narcoleptic ones, with mPEM having the highest 
AUC (0.79) when C were considered, and lMAI having the highest one (0.78) when SCC were taken 
into account. Testing NT1 against NT2 yielded an AUC of 0.79 using the RAI metric, thus showing 
that it has potential in distinguishing between narcolepsy types. Finally, mPEM had the highest AUC 
value (0.71) in distinguishing NT1+RBD and NT1-RBD, while the other metrics did not show 
satisfactory results. These results are generally promising because they show that automated EMG 
analysis during single-night PSG has the potential of discriminating between healthy controls and 
narcolepsy and between narcolepsy subtypes. The current study chose to focus on highly specific 
features for narcolepsy detection (at least 97% specificity) instead of seeking optimal diagnostic 
points balancing specificity and sensitivity in the ROC curve. Previous studies have likewise 
described highly specific features obtained from other sources, such as power spectral information in 
the EEG [11] and sleep stage transitions [12], and found sensitivities that were comparable to those 
found in the current study. However, since the obtained sensitivities were relatively low, this type of 
analysis might be considered as a supportive tool in the diagnosis of narcolepsy in combination with 
other tools, although extension to a larger sample will be needed to confirm this. In order to provide 
a more complete overview of the AUC analysis, the sensitivity and specificity obtained in 
correspondence of the optimal point of the ROC curve are presented in appendix Table A. 1. 
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Fig. 2 shows the correlation analysis between metrics and CSF-hcrt-1 levels. The linear 
relationships between variables were evaluated using Pearson’s correlation coefficient. However, 
since this is a parametric method sensitive to outliers in data, the correlation analysis was also 
conducted using Spearman’s correlation coefficient included in Appendix Fig. A. 2. These results 
were similar to the ones reported in Fig. 2. The analysis in Fig. 2 shows that the different metrics 
were generally characterized by significant correlations among them. These results show that the 
metrics investigated in this study generally agreed on the quantification of abnormal muscular 
activity. It is particularly interesting to observe a significant negative correlation between log-
transformed CSF-hcrt-1 values and metrics. This means that more muscular activity was observed in 
patients having lower CSF-hcrt-1 levels, thus supporting the hypothesis that CSF-hcrt-1 plays an 
important role in regulating muscle tone in narcolepsy during REM sleep.  
This is the first study to compare multiple EMG quantification methods on a single dataset 
containing NT1 and NT2 patients with the aim of investigating the role of automatically detected 
RSWA as a supportive tool in the diagnosis and differentiation of narcolepsy. Previous studies on 
automatic EMG quantification have focused primarily on RBD, iRBD in connection with 
neurodegenerative diseases such as Parkinson’s, or NT1 alone [25-29,35-37]. However, the currently 
implemented automatic methods present important limitations with regard to artifact removals. 
Specifically, none of the algorithms embed automatic detection of events that might affect the results 
in the calculation of abnormal muscular activity, such as sleep apneas, arousals, and noise. It is 
believed that adding the detection of such features should be taken into account when developing 
future automatic/data-driven EMG analysis methods. 
This study was limited by the following factors: 1) although a total of 81 subjects (71 after artifact 
rejection) were enrolled, the number of subjects in each group was very low. This limited the extent 
of the conclusions drawn based on the statistical analyses, and further studies with more data 
including idiopathic RBD and/or Parkinson groups should confirm the findings of this study. The 
small sample size might also explain the fact that NT1+RBD subjects presented a very similar 
muscular activity level as NT1-RBD, which was a relatively unexpected result. 2) The EMG analysis 
was performed on submental recordings only, and could be extended to include traces of legs and 
arms, since this has been shown to better differentiate RBD patients from controls in some studies 
[38]. However, the submental was not affected by periodic leg movements to the same degree as 
lower limb recordings [25]. 3) Many other detection approaches have been proposed in the literature, 
which could also have been investigated in this study. However, it chose to focus on methods which 
could be adapted to an automatic setting using chin EMG only, excluding those using multiple 
traces, such as the SINBAR method [38,39]. 4) Because of different hardware systems were used for 
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PSG recording, all EMG signals at 70 Hz had to be digitally low-pass filtered post hoc. This was a 
critical point, since some of the proposed algorithms (ie, mPEM, RAI and MAI) have originally been 
applied to EMG signals low-pass filtered at 100 Hz. It is unclear at this point whether the lack of 
frequency components in the 70-100 Hz range in the analyzed signals would have a significant effect 
on the final results, since at least one study used the same low-pass cut-off point at 70 Hz for 
analyzing RWSA in patients with RBD and comorbid OSA [40]. Further studies are needed to 
understand whether the different filtering might affect the results in a significant way. 
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Conclusions 
In summary, five automated methods evaluating nocturnal EMG activity were implemented in 
order to evaluate whether automatically detected RSWA could be used as a supportive tool in the 
diagnosis of narcolepsy and differentiation of narcolepsy subtypes. The results show that abnormal 
muscular activity is detected by most methods in NT1 subjects and that RAI is more sensitive than 
the other methods in identifying RBD as a comorbidity of NT1. The analysis of the diagnostic 
performances of the automatic methods show that mPEM yields promising results in the diagnosis of 
narcolepsy and identification of RBD in NT1, while RAI has the highest AUC in differentiating 
between NT1 and NT2. Moreover, it was found that CSF-hcrt-1 are associated with RSWA, 
underlying that hypocretin plays a role in the regulation of muscle activity during sleep. 
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APPENDIX A 
Table A.1. Comparison of the diagnostic value and performance of the five different metrics, given 
as optimal values of sensitivity/specificity.  
 sMAI lMAI mPEM RAI STREAM FR 
C vs 
NT1+NT2 
0.868/0.722 0.868/0.444 0.763/0.778 0.444/0.895 0.842/0.556 0.921/0.556 
SCC vs 
NT1+NT2 
0.947/0.467 0.868/0.533 0.790/0.600 0.533/0.842 0.974/0.133 0.921/0.467 
NT1 vs 
NT2 
1.000/0.133 0.870/0.467 0.957/0.333 0.800/0.739 0.913/0.267 0.783/0.733 
NT1-RBD 
vs 
NT1+RBD 
0.643/0.778 0.786/0.667 0.857/0.667 1.000/0.111 0.889/0.571 0.643/0.556 
 
C, healthy controls; SCC, sleep clinic controls; NT1RBD, type 1 narcolepsy with/without RBD; 
NT2, narcolepsy type 2; sMAI, short muscle activity index; lMAI, long muscle activity index; 
mPEM, modified phasic electromyographic metric; RAI, RAI atonia index; STREAM, supra-
threshold REM EMG activity metric; FR, Frandsen method  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 27
 
Fig. A. 1. Example of threshold chosen for identifying abnormal muscular activity with the muscle 
activity index method. It can be seen that if the threshold is set to twice the background level, the 
ECG artifacts in the EMG signal are wrongly considered as movements, while if the threshold is set 
to four times the baseline level, ECG artifacts are not seen as movements, while increased EMG 
activity is still accurately classified as movement. 
ECG, electrocardiogram; EMG, electromyogram 
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Fig. A. 2. Spearman correlation plots and analysis between metrics. All the metrics (RAI excluded) 
and CSF-hcrt-1 levels are log-transformed, and log(100-RAI) was used. Colors in the left boxes 
represent the correlation values, and significant p-values for the correlation are highlighted. In the 
diagonal, the distributions of the metrics are shown.  
sMAI, short muscle activity index; lMAI, long muscle activity index; mPEM, modified phasic 
electromyographic metric; RAI, REM atonia index; STREAM, supra-threshold REM EMG activity 
metric; FR, Frandsen method 
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HIGHLIGHTS 
• Comparison of five methods for automatic analysis of electromyogram (EMG) activity in 
narcolepsy. 
• Narcolepsy type 1 is characterized by increased rapid eye movement (REM) EMG activity. 
• Automatic EMG analysis in REM was a possible supportive tool in narcolepsy diagnosis. 
• Lower CSF hypocretin 1 level correlated with increased REM EMG activity. 
